Dexanabinol

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDexanabinol
Drug Alias NameDexanabinoneSinnabidolPRS-211007ETS-2101HU-211 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSolid tumoursBrain Injuries, TraumaticBrain Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandGermany +[5] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesE-Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmos CorpE-Therapeutics Plc
Active IndicationsN/A
Inactive IndicationsSolid tumoursBrain Injuries, TraumaticBrain Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia